Arkolith/Insider Trading/SLS/Form 4

Francomano Robert

Chief Commercial OfficerSELLAS Life Sciences Group, Inc. (SLS) · full profile →Form 4 · filed Dec 8, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2023Other(J)1K$1.08$1K21K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-124687) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML